Fougeroux, Cyrielle http://orcid.org/0000-0002-7566-8377
Goksøyr, Louise http://orcid.org/0000-0003-4508-9857
Idorn, Manja http://orcid.org/0000-0002-6769-9165
Soroka, Vladislav
Myeni, Sebenzile K.
Dagil, Robert http://orcid.org/0000-0002-5594-0716
Janitzek, Christoph M.
Søgaard, Max
Aves, Kara-Lee http://orcid.org/0000-0002-0068-7733
Horsted, Emma W.
Erdoğan, Sayit Mahmut http://orcid.org/0000-0001-7120-1609
Gustavsson, Tobias
Dorosz, Jerzy
Clemmensen, Stine
Fredsgaard, Laurits http://orcid.org/0000-0003-3891-3414
Thrane, Susan
Vidal-Calvo, Elena E. http://orcid.org/0000-0001-9655-2106
Khalifé, Paul http://orcid.org/0000-0001-6160-4674
Hulen, Thomas M. http://orcid.org/0000-0003-2475-6526
Choudhary, Swati
Theisen, Michael
Singh, Susheel K.
Garcia-Senosiain, Asier
Van Oosten, Linda
Pijlman, Gorben http://orcid.org/0000-0001-9301-0408
Hierzberger, Bettina http://orcid.org/0000-0001-5145-5265
Domeyer, Tanja http://orcid.org/0000-0002-3908-9546
Nalewajek, Blanka W.
Strøbæk, Anette http://orcid.org/0000-0001-9713-1119
Skrzypczak, Magdalena http://orcid.org/0000-0001-6059-5059
Andersson, Laura F.
Buus, Søren http://orcid.org/0000-0001-8363-1999
Buus, Anette Stryhn
Christensen, Jan Pravsgaard http://orcid.org/0000-0002-4299-9479
Dalebout, Tim J.
Iversen, Kasper
Harritshøj, Lene H.
Mordmüller, Benjamin http://orcid.org/0000-0001-9101-2768
Ullum, Henrik
Reinert, Line S. http://orcid.org/0000-0002-8317-0886
de Jongh, Willem Adriaan
Kikkert, Marjolein http://orcid.org/0000-0002-5779-7386
Paludan, Søren R. http://orcid.org/0000-0001-9180-4060
Theander, Thor G.
Nielsen, Morten A. http://orcid.org/0000-0003-2668-4992
Salanti, Ali
Sander, Adam F. http://orcid.org/0000-0002-8782-7830
Article History
Received: 17 July 2020
Accepted: 23 November 2020
First Online: 12 January 2021
Competing interests
: C.M.J., S.T., T.G.T., A.S., M.A.N., and A.F.S. are listed as co-inventors on a patent application covering the AP205 CLP vaccine platform technology (WO2016112921 A1) licensed to AdaptVac. Employees of AdaptVac (C.F., L.G., A.F.S., W.A.J.), a company commercializing virus-like particle display technology and vaccine, including several patents. ExpreS<sup>2</sup>ion employees, as ExpreS<sup>2</sup>ion is a listed company with IP on ExpreS<sup>2</sup> cells. W.D.J. is co-founder and owns ExpreS<sup>2</sup>ion shares. The other authors have no financial conflicts of interest.